Randomized, Double-blind, Placebo-controlled Phase I-Ib Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain.

Trial Profile

Randomized, Double-blind, Placebo-controlled Phase I-Ib Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs P 3914 (Primary)
  • Indications Dental pain
  • Focus Adverse reactions
  • Most Recent Events

    • 11 Apr 2012 Status changed from recruiting to suspended as reported by Clinical Trials Registry - India record.
    • 21 Mar 2012 Planned number of patients changed from 85 to 90 as reported by Clinical Trials Registry - India.
    • 18 Jan 2012 Piramal Healthcare as company and lead trial centre added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top